Research & Development



六一 二六夜夜视频网 四四夜夜擼日日日射 日日夜夜鲁 《宋蓉塘詩話》譏白太傅在杭州,憶妓詩多于憶民詩。此苛論也,亦腐論也。《關雎》一篇,文王輾轉反側,何以不憶王季、太王,而憶淑女耶?孔子厄于陳、蔡,何以不思魯君,而思及門耶?

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo